awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33945734-8EFA3994-38C9-4359-B145-8C9C94749F35
Q33945734-8EFA3994-38C9-4359-B145-8C9C94749F35
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33945734-8EFA3994-38C9-4359-B145-8C9C94749F35
Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations.
P2860
Q33945734-8EFA3994-38C9-4359-B145-8C9C94749F35
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33945734-8EFA3994-38C9-4359-B145-8C9C94749F35
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
07263ac65a2273f9524d37beab764e5bedfb33cc
P2860
An alternative inhibitor overcomes resistance caused by a mutation of the epidermal growth factor receptor.